🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/06/2007 46,47 46,99 45,80 46,13 -0,43% 2,57% 11.768.516
22/06/2007 46,68 47,14 46,05 46,33 -1,52% 2,33% 15.201.240
21/06/2007 46,80 47,26 46,24 47,04 +0,08% 2,18% 12.389.980
20/06/2007 47,71 47,80 46,96 47,00 -2,11% 1,76% 14.710.776
19/06/2007 48,33 48,65 47,88 48,02 -0,61% 1,60% 9.811.062
18/06/2007 48,57 48,66 47,99 48,31 -0,20% 1,39% 7.820.595
15/06/2007 48,56 49,22 48,14 48,41 +1,00% 2,22% 14.308.449
14/06/2007 48,33 48,33 47,81 47,93 -0,87% 1,09% 10.972.979
13/06/2007 48,05 48,54 47,43 48,35 +0,90% 2,30% 12.061.537
12/06/2007 48,35 48,71 47,91 47,92 -1,63% 1,66% 11.830.767
11/06/2007 48,00 49,00 47,75 48,71 +1,81% 2,60% 13.044.142
08/06/2007 48,00 48,18 47,36 47,84 -0,40% 1,71% 11.885.473
07/06/2007 48,13 48,44 47,93 48,03 -0,83% 1,05% 14.175.667
06/06/2007 48,66 48,96 48,32 48,44 -1,32% 1,31% 12.255.102
05/06/2007 49,30 49,32 48,41 49,08 -0,60% 1,86% 15.301.534
04/06/2007 49,67 49,67 49,04 49,38 -0,75% 1,27% 15.318.826
01/06/2007 50,11 50,48 49,50 49,75 -0,59% 1,94% 11.650.616
31/05/2007 50,21 50,74 50,05 50,05 -0,49% 1,39% 11.751.958
30/05/2007 50,72 50,72 49,58 50,30 -1,29% 2,24% 15.706.166
29/05/2007 51,36 51,54 50,57 50,95 -0,56% 1,88% 10.423.513
25/05/2007 51,23 51,29 51,03 51,24 -0,09% 0,50% 13.246.510
24/05/2007 51,43 52,09 50,79 51,29 -1,10% 2,52% 10.597.271
23/05/2007 51,89 52,19 51,62 51,86 +0,37% 1,10% 10.507.353
22/05/2007 51,62 52,61 51,53 51,67 +0,67% 2,11% 15.245.256
21/05/2007 50,60 52,19 50,57 51,33 +1,01% 3,19% 20.620.134
18/05/2007 50,15 50,81 49,86 50,81 +1,51% 1,90% 14.401.092
17/05/2007 50,28 50,55 49,93 50,06 -0,44% 1,23% 9.680.481
16/05/2007 50,57 50,57 49,76 50,28 +0,13% 1,60% 11.380.127
15/05/2007 49,68 50,27 49,60 50,21 +1,04% 1,34% 12.289.686
14/05/2007 49,62 50,21 49,49 49,69 +0,15% 1,44% 8.657.947